Maged Shenouda - Sep 9, 2024 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Financial Officer
Signature
/s/ Maged Shenouda
Stock symbol
RLMD
Transactions as of
Sep 9, 2024
Transactions value $
$149,701
Form type
4
Date filed
9/11/2024, 05:46 PM
Previous filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Purchase $20.9K +8.19K +23.48% $2.55 43.1K Sep 9, 2024 Direct F1, F2
transaction RLMD Common Stock Purchase $57.7K +21.1K +49% $2.73 64.2K Sep 10, 2024 Direct F1, F3
transaction RLMD Common Stock Purchase $71.2K +24.1K +37.56% $2.95 88.3K Sep 11, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2 Purchase prices range from $2.49 to $2.60 per share, inclusive.
F3 Purchase prices range from $2.70 to $2.75 per share, inclusive.
F4 Purchase prices range from $2.79 to $3.05 per share, inclusive.